Wolverine Trading
BLFS icon

Wolverine Trading’s BioLife Solutions BLFS Stock Holding History

Wolverine Trading’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,200
Closed -$270K – 6263
2021
Q2 		$270K Sell
6,200
-45,000
-88% -$1.59M ﹤0.01% 4566
2021
Q1 		$1.84M Buy
+51,200
New +$2.02M ﹤0.01% 2016

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Wolverine Trading's BLFS Position: Q1 2021 in Review

Wolverine Trading sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 5,061 shares — an estimated $200K sold.

Wolverine Trading first reported a position in BLFS in Q4 2020 and held it in 1 quarter. The position peaked at $207K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

  • Wolverine Trading reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 5,061 BioLife Solutions shares in Q1 2021, an estimated $200K.
  • Wolverine Trading first reported a position in BioLife Solutions in Q4 2020 and held it in 1 quarter.
  • Wolverine Trading's BioLife Solutions position peaked at $207K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.